Loading...
Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer
The recent approval by the FDA of cancer vaccines and drugs that blockade immunological negative regulators has further enhanced interest in promising approaches of the immunotherapy of cancer. However, the disappointingly short life extension has also underscored the need to better understand the m...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2013
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3576025/ https://ncbi.nlm.nih.gov/pubmed/23334369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00109-013-1001-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|